HRH2 and colorectal carcinoma: Although some Hrh2 antagonists, such as ranitidine and famotidine, were found to lack tumor-inhibitory effects [42], cimetidine was able to suppress the growth of CRC implants in mice [26], chemically-induced intestinal cancers in rats [43] and human CRC [23] by inhibition of angiogenesis [26].